Mainstream

Neurocrine refines INGREZZA net sales guidance to $2.5B-$2.55B while CRENESSITY surges, driving revenue growth and pipeline expansion

Neurocrine refines INGREZZA net sales guidance to $2.5B-$2.55B while CRENESSITY surges, driving revenue growth and pipeline expansion

Post ContentnbixRead More

You might also be interested in reading XRP Rejects $3.09 Resistance, Bears Target $2.96 Demand Zone.

July 31, 2025
In Mainstream